Business
CSL (ASX:CSL) share price up after AstraZeneca vaccine approved for use in Australia
The CSL Limited (ASX: CSL) share price is up by 2.73% today. The positive price movement comes on the heels of news the Australian government has approved use of its COVID-19 vaccine within the country.
At the time of writing, shares in the pharmaceutical giant are trading for $260.87 – up 2.44%. By comparison the S&P/ASX 200 Index (ASX: XJO) is up 0.66%.
Let’s take a closer at the government’s announcement.
CSL-made AstraZeneca vaccine will be used in Australia
The CSL share price is responding well to today’s news. The Therapeutic Goods Administration (TGA) announced late on Sunday it had approved use of the…
-
Noosa News9 hours agoShocking moment Bradley Donald Towle arrested after Bruce Hwy rampage and shooting on Sunshine coast
-
Noosa News16 hours agoMollie O’Callaghan admits to doubts, wins gold at Australian Open Swimming Championships
-
General10 hours agoNSW Police to provide update on Sydney woman’s kidnap from Bankstown home and killing
-
General22 hours agoFounder Schwab quits as World Economic Forum chair